
Calliditas Therapeutics AB
STO:CALTX

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CALTX's stock price target?
Not Available
CALTX doesn't have any price targets made by Wall Street professionals.
What is Calliditas Therapeutics AB's Revenue forecast?
Projected CAGR
57%
The
compound annual growth rate
of Calliditas Therapeutics AB's revenue for the next 3 years is
57%.